- VernacularTitle:2025年版《中国药典》三部增修订概况
- Author:
Yan CAO
1
;
Xiong ZHAO
1
;
Xiaojuan WANG
1
;
Huiyi CHEN
1
;
Huiyi LI
1
Author Information
- Publication Type:Journal Article
- Keywords: Chinese Pharmacopoeia; drug standard; new admission and revision
- From: Drug Standards of China 2025;26(1):28-33
- CountryChina
- Language:Chinese
- Abstract: "Chinese Pharmacopoeia"is the legal basis for drug development,production,operation,use and man-agement in China,and the Chinese Pharmacopoeia 2025 Edition is going to be issued and implemented.This article introduces the revision and amendment situations,analyzes the characteristics of the new edition of the Pharmaco-poeia and the future development direction of national standards for better understanding and implementation of the latest edition of pharmacopoeia.

